Andes Biotechnologies is a leading nucleic acid-based drug discovery and development company focused on solid tumor cancers.
Sign up for LAVCA’s bi-weekly Latin American Private Capital Update and the LatAm Venture Bulletin, produced specifically for venture investors, entrepreneurs, and technology startups in the early stage ecosystem.
27-Jan-2023
23-Jan-2023
19-Jan-2023
11-Jan-2023
30-Dec-2022